BioInfra Life Science Inc.

A266470

KR7266470004

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 23:00:00 27/06/2024 BST			5-day change	1st Jan Change
301 ^KRW	-3.53%		+0.33%	-17.53%

2021	BioInfra Life Science Inc. announced that it has received KRW 4.4999845 billion in funding from SBI Investment KOREA Co., Ltd., DSC Investment Inc., Skywalk Asset Management Co., Ltd.	CI
2021	BioInfra Life Science Inc. announced that it has received KRW 1.999998 billion in funding from Korea Investment Partners Co. Ltd., Skywalk Asset Management Co., Ltd.	CI

BIOINFRA Life Science Inc. announced that it has received KRW 5.9999922 billion in funding from Korea Investment Partners Co. Ltd., Lion Asset Management Co., Ltd., Root N Global Investors Co., Ltd.

July 15, 2019

On July 16, 2019, BIOINFRA Life Science Inc. closed the transaction.

Latest news about BioInfra Life Science Inc.

BioInfra Life Science Inc. announced that it has received KRW 4.4999845 billion in funding from SBI Investment KOREA Co., Ltd., DSC Investment Inc., Skywalk Asset Management Co., Ltd.	22/06/21	CI
BioInfra Life Science Inc. announced that it has received KRW 1.999998 billion in funding from Korea Investment Partners Co. Ltd., Skywalk Asset Management Co., Ltd.	15/06/21	CI
BioInfra Life Science Inc. announced that it expects to receive KRW 4.4999845 billion in funding from SBI Investment KOREA Co., Ltd., DSC Investment Inc., Skywalk Asset Management Co., Ltd.	14/06/21	CI
BioInfra Life Science Inc. announced that it expects to receive KRW 2.999986 billion in funding from Korea Investment Partners Co. Ltd., Skywalk Asset Management Co., Ltd.	16/05/21	CI
BIOINFRA Life Science Inc. announced that it has received KRW 4 billion in funding from Hizeasset Investment Co., Ltd	17/12/19	CI
BIOINFRA Life Science Inc. announced that it expects to receive KRW 4 billion in funding from Hizeasset Investment Co., Ltd	12/12/19	CI
BIOINFRA Life Science Inc. announced that it has received KRW 5.9999922 billion in funding from Korea Investment Partners Co. Ltd., Lion Asset Management Co., Ltd., Root N Global Investors Co., Ltd.	15/07/19	CI
BIOINFRA Life Science Inc. announced that it expects to receive KRW 5.9999922 billion in funding from Korea Investment Partners Co. Ltd., Lion Asset Management Co., Ltd., Root N Global Investors Co., Ltd.	30/06/19	CI
BIOINFRA Inc. announced that it expects to receive KRW 1.5999938 billion in funding	26/09/18	CI

Chart BioInfra Life Science Inc.

Duration

Period

More charts

BioInfra Life Science Inc is a Korea-based company mainly engaged in the research and development and manufacture of protein chip contents. The Company provides diagnostic testing services and research services. The Company provides services such as multi-biomarker blood tests, diagnosis kit development, biomarker discovery, and peptide chip development.

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
BIOINFRA LIFE SCIENCE INC.	-17.53%	3.08M
MODERNA, INC.	+19.41%	45.51B
LONZA GROUP AG	+38.65%	39.36B
IQVIA HOLDINGS INC.	-8.62%	38.52B
ALNYLAM PHARMACEUTICALS, INC.	+26.95%	30.74B
CELLTRION, INC.	-13.50%	26.03B
ICON PUBLIC LIMITED COMPANY	+10.74%	25.92B
UNITED THERAPEUTICS CORPORATION	+44.87%	14.13B
MEDPACE HOLDINGS, INC.	+34.36%	12.73B
BIO-TECHNE CORPORATION	-7.14%	11.29B

Other Biotechnology & Medical Research

BioInfra Life Science Inc.

Equities

A266470

KR7266470004

Biotechnology & Medical Research

BIOINFRA Life Science Inc. announced that it has received KRW 5.9999922 billion in funding from Korea Investment Partners Co. Ltd., Lion Asset Management Co., Ltd., Root N Global Investors Co., Ltd.

Latest news about BioInfra Life Science Inc.

Chart BioInfra Life Science Inc.

Company Profile

Sector Other Biotechnology & Medical Research